DSM Corp.

As of March 31, 2026, DSM Corp. carries a market capitalization of 87.32B, placing it among publicly traded companies globally. Its enterprise value stands at 202.69B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2026, DSM Corp. has 26.66M shares outstanding.

These figures are as of March 31, 2026. The price-to-sales ratio is 1.65, and the price-to-book ratio stands at 0.79.

These figures are as of March 31, 2026. The EV/Sales ratio of 4.84 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 202.69B versus a market cap of 87.32B, with the gap driven by net debt and cash on the balance sheet.

As of March 31, 2026, DSM Corp. maintains a current ratio of 0.52, meaning it holds 0.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 111.70, indicating elevated leverage, while an interest coverage ratio of -1.54 demonstrates limited ability to service its debt obligations.

Over the twelve months ended March 31, 2026, DSM Corp. posted a negative return on equity (ROE) of -1.79, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -0.87, reflecting losses generated across the asset base. The company generates approximately 229.28M in revenue per employee across its workforce of 182.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 2.79 indicates how many times DSM Corp. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended March 31, 2026, DSM Corp. recorded an income tax benefit of -2.56M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -1.57B and -1.57B in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 23, 2026, DSM Corp.'s stock has declined approximately 16.01% over the past 52 weeks. The 50-day moving average sits at 2,743.60, while the 200-day moving average is 2,957.92.

Over the twelve months ended March 31, 2026, DSM Corp. generated 41.84B in revenue and converted that into -1.57B in net income, yielding earnings per share of -73.62. EBITDA reached -3.46B, while operating income came in at -7.68B.

As of March 31, 2026, DSM Corp. holds 8.55B in cash and equivalents against 123.92B in total debt, resulting in a net debt position of 86.24B. Total book value stands at 110.94B, with working capital of -32.53B providing operational flexibility.

These figures cover the twelve months ended March 31, 2026.

Over the twelve months ended March 31, 2026, DSM Corp. posted a gross margin of 34.37, reflecting its pricing power and cost economics. The operating margin of -18.36 and net profit margin of -3.75 provide insight into operational efficiency.

DSM Corp.'s most recent stock split took place on May 18, 2026 with a 5:1 split ratio.

As of March 31, 2026, DSM Corp. has an Altman Z-Score of -0.23, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.